News

BioLamina appoints Klaus Langhoff-Roos as new CEO

BioLamina appoints Klaus Langhoff-Roos as new CEO

Strategic expansion into the Norwegian fund market through Atle's acquisition of a majority share in First Fondene AS

Strategic expansion into the Norwegian fund market through Atle's acquisition of a majority share in First Fondene AS

Bure's investment in active management strengthened by Atle's co-ownership in Amaron Holding AB

Bure's investment in active management strengthened by Atle's co-ownership in Amaron Holding AB

Bure becomes new co-owner of Mentimeter

Bure becomes new co-owner of Mentimeter

Xvivo presents positive data from heart preservation clinical trial

Xvivo presents positive data from heart preservation clinical trial

Successful launch of Ovzon 3

Successful launch of Ovzon 3

Switching to solid-state lasers reduces Mycronic’s climate impact

Switching to solid-state lasers reduces Mycronic’s climate impact

Bure increases its shareholding in BioLamina to 52%

Bure increases its shareholding in BioLamina to 52%